Artiva Biotherapeutics, Inc. (ARTV) Reports Q2 Loss of $0.87

Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) reported Q2 EPS of ($0.87), versus $0.00 reported last year.

For earnings history and earnings-related data on Artiva Biotherapeutics, Inc. (ARTV) click here.

You May Also Be Interested In

• Citi upgrades Bath & Body Works to Buy with $25 price target
• Compass Point Starts Gorilla Tech Group/ (GRRR) at Buy
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance